OM1 Earns Frost & Sullivan’s 2024 North American New Product Innovation Award for Transforming Real-world Evidence Analytics Solutions Industry with Its Pioneering AI-powered Platforms
OM1's innovative solutions, such as Orion, Lyra, and Polaris, are revolutionizing patient journey analysis and clinical research through deep AI integration and highly personalized insights. SAN ANTONIO, Sept. 18, 2024 /PRNewswire/ -- Frost & Sullivan recently researched the real-world evidence analytics (RWE) solutions industry and, based on its findings, recognizes OM1 with the 2024 North American...
Insilico Medicine Reports Positive Phase IIa Results for ISM001-055, a Novel First-in-Class Drug Treatment for Idiopathic Pulmonary Fibrosis (IPF) Designed Using Generative AI
ISM001-055 is a novel drug designed in-house using generative AI to target TNIK (Traf2- and NCK- interacting kinase) and has progressed through Phase IIa clinical testing. Preliminary results from this 12-week study demonstrated that ISM001-055 possesses a favorable safety profile and dose-dependent response in lung function in patients with IPF. ISM001-055's positive Phase IIa results represent a proof-of-concept...
Kintara Therapeutics Reminds Stockholders to Vote by Thursday to Allow for Completion of the Proposed Merger with TuHURA Biosciences
Stockholders must vote by 11:59 p.m. ET on September 19, 2024 for their vote to count A "FOR" vote on Proposals 3 & 5 by holders of a majority of the voting power of Kintara's outstanding shares as of August 14, 2024 is required to allow for completion the proposed merger...
Prof. Gang Shen Presents Smartee S8 Orthopedic Therapy at ACAS Sydney
SYDNEY, Sept. 18, 2024 /PRNewswire/ -- The Australian Clear Aligner Society (ACAS) recently brought together top orthodontic experts worldwide. Among the distinguished speakers was Smartee Chief Scientist, Prof. Gang Shen, who delivered an insightful presentation titled "The Clear S8 Orthopedic Therapy: Fundamental Mechanisms, Therapeutic Procedures, and Clinical Efficiency." His talk focused on cutting-edge advancements in mandibular repositioning technology. Prof. Gang...
Biosyngen’s first-in-class CAR-T asset targeting solid tumors has entered pivotal phase II trial, Phase I trial data debut at ESMO 2024 Annual Congress
BARCELONA, Spain, Sept. 18, 2024 /PRNewswire/ -- The highly anticipated 2024 European Society for Medical Oncology (ESMO) Annual Congress has taken place in Barcelona, Spain. As one of the most influential annual gatherings in oncology, this congress brings together leading cancer experts and researchers from around the globe, showcasing the latest advancements...
Frost & Sullivan grants the Global Medical Imaging Foundation Model Innovation Award to Hangzhou Diagens Biotechnology Co.,Ltd.
SHANGHAI, Sept. 18, 2024 /PRNewswire/ -- Frost & Sullivan is pleased to announce that the 18th Growth Innovation Leadership (GIL) Summit and the 3rd New Investment Event (NIE 2024), was held in Shanghai from August 27 to 30, 2024, co-hosted by LeadLeo. Based on the research and analysis of the global medical imaging foundation model in recent years, as...
TVM Capital Healthcare Announces Investment in Human Longevity, Inc. as Part of its Strategy of Supporting Disease Prevention and Healthy Aging
HLI is one of the most established, global longevity science companies and committed to accelerating living to 100+ years of a healthy, active, and mobile life DUBAI, UAE and RIYADH, Saudi Arabia, Sept. 18, 2024 /PRNewswire/ -- TVM Capital Healthcare, an international healthcare expansion and growth capital firm, today announced a...
Clarivate Announces 15th Annual Pharmavision India Conference Agenda
Industry leaders to discuss AI in healthcare, cell and gene therapy, market access and more at premier life sciences event LONDON, Sept. 18, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading global provider of transformative intelligence, today announced the full agenda for the 15th annual Clarivate Pharmavision India conference. The 15th edition of Pharmavision...
AI Plus Clinic Tamaplaza Enhances System to Provide Rapid Diagnosis and Peace of Mind with Remote Robots Starting September 2024
YOKOHAMA, Japan, Sept. 18, 2024 /PRNewswire/ -- - New System Integrates AI Technology and Home Healthcare Launched in July 2024 - AI Plus Clinic Tamaplaza, based in Aoba-ku, Yokohama, Kanagawa Prefecture, operating under Kouetsukai Medical Corporation, has announced a new medical system integrating AI technology and home healthcare, aiming to reduce patient waiting times and provide rapid diagnosis and treatment....
inHearing Technology Inc. Announced the Acquisition of Intricon’s Hearing Health Business
ST. PAUL, Minn., Sept. 18, 2024 /PRNewswire/ -- inHearing Technology Inc., a wholly-owned subsidiary of Huizhou Jinghao Medical Technology Co., Ltd., announced on September 11, 2024, the acquisition of Intricon's Hearing Health Business. Acquisition Announcement For more than four decades, Intricon Inc. has been a pioneer in the hearing health industry, specializing in the design,...
